This inventor holds 25 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents, primarily in G Protein-Coupled Receptors. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc.. Active years: 1998-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (1999 - 2002)
- Tsuchiura, JP (1998 - 2009)
- Ibaraki, JP (2007 - 2010)
- Fujisawa, JP (2015)
- Kanagawa, JP (2015)
Company Filing History:
13 out of 1,226 
12 out of 1,858 
Years Active: 1998-2015
Areas of Expertise:
Title: **Masaki Hosoya: A Pioneer in Pancreatic Cell Production**
Introduction
Masaki Hosoya, based in Ibaraki, Japan, is a prominent inventor recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 25 patents, he has focused his research on innovative methods to produce pancreatic hormone-producing cells, a crucial advancement for diabetes treatment and related conditions.
Latest Patents
Hosoya's latest patents include groundbreaking methods for producing pancreatic hormone-producing cells. One patent discloses a technique that mimics pancreatogenesis, allowing for the efficient production of these vital cells. This method involves subjecting stem cells to a series of systematic steps aimed at enhancing differentiation into pancreas cells. Another notable invention provides an advanced procedure for the stable and large-scale production of pancreatic hormone-producing cells, which also includes a medicament containing these cells and a screening method employing them.
Career Highlights
Throughout his career, Hosoya has been associated with esteemed organizations such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His work at these companies has been pivotal in advancing the understanding and production of pancreatic cells, ultimately contributing to medical innovations in treating pancreatic-related health issues.
Collaborations
Masaki Hosoya has collaborated with esteemed colleagues, including Shuji Hinuma and Ryo Fujii. Their joint efforts have fostered a dynamic research environment, leading to the development of innovative solutions in the field of pancreatic cell production and regenerative medicine.
Conclusion
Masaki Hosoya's work showcases his commitment to advancing biotechnological innovations. His patents represent significant strides in the efficient production of pancreatic hormone-producing cells, which hold great promise for improving treatment options for those affected by pancreatic disorders. His contributions not only demonstrate the power of innovation in science but also highlight the importance of collaboration in achieving groundbreaking advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile